Wave Life Sciences is trading at $3.18, with a -5.07% move alongside broader biotech sector weakness.
- The broader biotech sector is down 2.08%; available evidence points to sector weakness rather than a confirmed company-specific catalyst.
- No company-specific news for October 23 was identified, and a market listing showed no headlines for that date. Third-quarter results are scheduled for October 27, but no evidence links them directly to todayβs move.